SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

CytomX Therapeutics Q1 EPS $0.260 vs $(0.31) In Same Qtr. Last Year, Sales $49.593M Beat $19.880M Estimate

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly earnings of $0.260 per share which beat the analyst consensus estimate of $(0.460) by 156.52 percent. This is a 183.87 percent increase over losses of $(0.310) per

Benzinga · 05/07/2020 21:18

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly earnings of $0.260 per share which beat the analyst consensus estimate of $(0.460) by 156.52 percent. This is a 183.87 percent increase over losses of $(0.310) per share from the same period last year. The company reported quarterly sales of $49.593 million which beat the analyst consensus estimate of $19.880 million by 149.46 percent. This is a 68.20 percent increase over sales of $29.485 million the same period last year.